BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 18753185)

  • 1. Stress-related mucosal bleeding in critically ill oncology patients.
    Bruno JJ; Canada TW; Wakefield CD; Nates JL
    J Oncol Pharm Pract; 2009 Mar; 15(1):9-16. PubMed ID: 18753185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.
    Barkun AN; Bardou M; Pham CQ; Martel M
    Am J Gastroenterol; 2012 Apr; 107(4):507-20; quiz 521. PubMed ID: 22290403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-induced ulcer bleeding in critically ill patients.
    Ali T; Harty RF
    Gastroenterol Clin North Am; 2009 Jun; 38(2):245-65. PubMed ID: 19446257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
    Zhou X; Fang H; Xu J; Chen P; Hu X; Chen B; Wang H; Hu C; Xu Z
    BMC Gastroenterol; 2019 Nov; 19(1):193. PubMed ID: 31752703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis.
    Pongprasobchai S; Kridkratoke S; Nopmaneejumruslers C
    J Med Assoc Thai; 2009 May; 92(5):632-7. PubMed ID: 19459523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of stress ulcers in critically ill patients.
    Yang YX; Lewis JD
    Semin Gastrointest Dis; 2003 Jan; 14(1):11-9. PubMed ID: 12610850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
    Tofil NM; Benner KW; Fuller MP; Winkler MK
    J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis.
    Pimentel M; Roberts DE; Bernstein CN; Hoppensack M; Duerksen DR
    Am J Gastroenterol; 2000 Oct; 95(10):2801-6. PubMed ID: 11051351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit.
    Murphy CE; Stevens AM; Ferrentino N; Crookes BA; Hebert JC; Freiburg CB; Rebuck JA
    Pharmacotherapy; 2008 Aug; 28(8):968-76. PubMed ID: 18657013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
    Zhou JF; Wan XY; Huang W; Han LL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal management of upper gastrointestinal bleeding caused by stress gastropathy.
    Constantin VD; Paun S; Ciofoaia VV; Budu V; Socea B
    J Gastrointestin Liver Dis; 2009 Sep; 18(3):279-84. PubMed ID: 19795020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group.
    Cook D; Guyatt G; Marshall J; Leasa D; Fuller H; Hall R; Peters S; Rutledge F; Griffith L; McLellan A; Wood G; Kirby A
    N Engl J Med; 1998 Mar; 338(12):791-7. PubMed ID: 9504939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
    MacLaren R; Reynolds PM; Allen RR
    JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group.
    Cook DJ; Fuller HD; Guyatt GH; Marshall JC; Leasa D; Hall R; Winton TL; Rutledge F; Todd TJ; Roy P
    N Engl J Med; 1994 Feb; 330(6):377-81. PubMed ID: 8284001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: prevention of stress-related mucosal bleeding with proton-pump inhibitors.
    Maton PN
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():45-52. PubMed ID: 16303037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When should stress ulcer prophylaxis be used in the ICU?
    Quenot JP; Thiery N; Barbar S
    Curr Opin Crit Care; 2009 Apr; 15(2):139-43. PubMed ID: 19578324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
    Reynolds PM; MacLaren R
    Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of prescriber perceptions about the prevention of stress-related mucosal bleeding in the intensive care unit.
    Preslaski CR; Mueller SW; Kiser TH; Fish DN; MacLaren R
    J Clin Pharm Ther; 2014 Dec; 39(6):658-62. PubMed ID: 25243327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.